Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 01032F

The Bachelor of Biomedical Science consists of a prescribed series of courses designed to develop a range of theoretical and practical skills. The course includes a general introduction to biological science, plus coverage of such topics as anatomy, molecular and cell biology, microbiology, biochemistry, genetics, pathology, human physiology, immunology, neuroscience, and reproductive biology. In addition to the specific scientific knowledge gained through in-depth study, the degree aims to develop the capacity to understand and apply modern scientific principles to both scientific and non-scientific audiences and to critically analyse information.The program is delivered using a number of teaching platforms including workshops, seminars and discussions. Furthermore, a six-week (150 hour) industry placement will allow you to apply your new skills in range of professional settings, such as medical laboratories and research facilities.

Structure

  • 3 core curriculum courses
  • 17 required courses
  • 3 elective courses
  • 1 industry practicum

Subjects

  • Biomedical science

Standard entry requirements

  • Applicants with recent Secondary Education: Indicative ATAR of 70 with a score of 50+ in ATAR English, ATAR Literature or ATAR English as an Additional Language or Dialect (EALD) OR Minimum International Baccalaureate (IB) score of 24
  • Applicants with Higher Education Study. Other university studies completed at undergraduate level or higher, a minimum of 4 successfully completed subjects
  • OR Successful completion of the Notre Dame Tertiary Pathway Program or of another Enabling Program at a level deemed sufficient by the University.

Study pathways

Applicants may consider a Notre Dame Australia enabling program as an entry pathway.

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course

Are you currently in Australia?

You must agree before submitting.

Subscribe to our newsletter

Join the conversation